Genenta Science S.p.A. financial data

Symbol
GNTA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Olgettina, No. 58, Milan, Italy
State of incorporation
Italy
Former names
Genenta Science S.r.l. (to 5/19/2021)
Latest financial report
20-F - Q4 2023 - Mar 29, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.2M shares +0%
Common Stock, Shares, Outstanding 18.2M shares +0%
Common Stock, Value, Issued 67.3M EUR +1.11%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 158K EUR

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.69M EUR -87.6%
Marketable Securities, Current 15.1M EUR
Cash, Cash Equivalents, and Short-term Investments 18.8M EUR
Other Assets, Current 64.7K EUR -70.5%
Assets, Current 21.3M EUR -33%
Property, Plant and Equipment, Net 83K EUR -25.7%
Intangible Assets, Net (Excluding Goodwill) 87K EUR
Other Assets, Noncurrent 1.6M EUR +29%
Assets 22.3M EUR -33.2%
Accounts Payable, Current 1.04M EUR +532%
Accrued Liabilities, Current 202K EUR -71.6%
Liabilities, Current 1.74M EUR -20.5%
Operating Lease, Liability, Noncurrent 21K EUR
Other Liabilities, Noncurrent 14.6K EUR -46.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 231K EUR
Retained Earnings (Accumulated Deficit) -47.1M EUR -32.9%
Stockholders' Equity Attributable to Parent 20.4M EUR -34.4%
Liabilities and Equity 22.3M EUR -33.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 59.7M shares 0%
Common Stock, Shares, Issued 18.2M shares +0%
Common Stock, Par or Stated Value Per Share 0 EUR/shares
Deferred Tax Assets, Valuation Allowance 12.4M EUR +28.4%
Deferred Tax Assets, Gross 12.4M EUR +28.4%
Lessee, Operating Lease, Liability, to be Paid 22.7K EUR
Property, Plant and Equipment, Gross 137K EUR +10.5%
Operating Lease, Liability, Current 12.2K EUR
Deferred Tax Assets, Operating Loss Carryforwards 11.8M EUR +28%